Across these studies, the notion of food aversion and nausea through GLP-1 signaling has been implied, but there lacks sufficient evidence to support this claim [56]
10 Interestingly, however, only liraglutide 3.0 mg reduced the incremental glucose response during the 5-h meal test (iAUC 0300 min ), by 26% compared with both 1.8 mg and placebo, in the face of similar improvements in postprandial insulin, C-peptide and glucagon responses and body weight loss between liraglutide doses
Diabetes Metab Res Rev (2023):e3679
Identifying the receptor would enable structure-activity relationship optimization
datos preliminares sugieren reduccin de presin arterial sistlica 510 mmHg, mejora de perfil lipdico (triglicridos -25%, LDL -8%) y reduccin de marcadores inflamatorios (PCR-us)
Supports Metabolic Resilience Balanced blood sugar and insulin responses helped subjects avoid energy crashes and mood swings